Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

Oxford Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for OXFORD PHARMS, and what generic and branded alternatives to OXFORD PHARMS drugs are available?

OXFORD PHARMS has thirty-five approved drugs.

Summary for Oxford Pharms
US Patents:0

Drugs and US Patents for Oxford Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms RISPERIDONE risperidone TABLET;ORAL 078071-001 Jun 17, 2009 AB RX No No   Start Trial   Start Trial
Oxford Pharms TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 072193-001 Feb 2, 1989 AB RX No No   Start Trial   Start Trial
Oxford Pharms BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040706-001 Feb 14, 2008 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.